Briacell Therapeutics Corp (BCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
10-2021 | 07-2021 | 04-2021 | 01-2021 | 10-2020 | |
Operating Expenses | 2,285 | 1,599 | 4,807 | 190 | 380 |
Operating Income | -2,285 | -1,599 | -4,807 | -190 | -380 |
Interest Expense | 1 | -45 | 62 | 46 | 16 |
Other Income | -25,248 | -14,555 | 7,819 | 0 | -25 |
Pre-tax Income | -27,534 | -16,109 | 2,950 | -236 | -421 |
Net Income Continuous | -27,534 | -16,109 | 2,950 | -236 | -421 |
Net Income | $-27,534 | $-16,109 | $2,950 | $-236 | $-421 |
EPS Basic Total Ops | -1.81 | -2.85 | 0.63 | -0.30 | -0.54 |
EPS Basic Continuous Ops | -1.81 | -2.83 | 0.62 | -0.31 | -0.54 |
EPS Diluted Total Ops | -1.81 | -2.85 | 0.63 | -0.30 | -0.54 |
EPS Diluted Continuous Ops | -1.81 | -2.83 | 0.62 | -0.31 | -0.54 |
EBITDA(a) | $-2,281 | $-1,595 | $-4,803 | $-186 | $-377 |